In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
Milatovic
Dana
D
Schmitz
Franz-Josef
FJ
Verhoef
Jan
J
Fluit
Ad C
AC
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology; D005060:Europe; D006801:Humans; D007769:Lactams; D008826:Microbial Sensitivity Tests / Q000706:statistics & numerical data; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D007769:Lactams; D047090:beta-Lactams; C107057:fropenem